Effects of silperisone on the excitation process in Ranvier nodes

General Physiology and Biophysics

Volumn 20, Issue 2, 2001, Pages 157-173

  During T ^a   Koppenhöfer, Elhard ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

Antispastic drug; Demyelinating diseases; K+ channel blocker; Node of Ranvier; Silperisone

Indexed keywords

BERGAPTEN; N [(DIMETHYL 4 FLUOROBENZYLSILYL)METHYL]PIPERIDINE; PIPERIDINE DERIVATIVE; POTASSIUM; POTASSIUM CHANNEL BLOCKING AGENT; PSORALEN DERIVATIVE; SILPERISONE; SODIUM; SPASMOLYTIC AGENT; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEMYELINATING DISEASE; DISSOCIATION CONSTANT; NERVE EXCITABILITY; NONHUMAN; POTASSIUM CURRENT; RANVIER NODE; SODIUM TRANSPORT; SPIKE; STEADY STATE; XENOPUS;

ACTION POTENTIALS; ANIMALS; BENZENE DERIVATIVES; CALIBRATION; DOSE-RESPONSE RELATIONSHIP, DRUG; MEMBRANE POTENTIALS; PARASYMPATHOLYTICS; PATCH-CLAMP TECHNIQUES; PERMEABILITY; PIPERIDINES; POTASSIUM CHANNEL BLOCKERS; RANVIER'S NODES; SODIUM; SODIUM CHANNELS; XENOPUS LAEVIS;

ANIMALIA; ANURA;

EID: 0342902130     PISSN: 02315882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Århem P., Frankenhaeuser (1974): Local anesthetics: effects on permeability properties of nodal membrane in myelinated nerve fibres from Xenopus. Potential clamp experiments. Acta physiol. scand. 91, 11-21
2. Århem P., Frankenhaeuser B., Kristbjarnarson H. (1982): Inactivation of the potassium transport system of myelinated nerve in the presence of a cyclic ionophore. Acta physiol. scand. 114, 593-600
3. Armstrong C. M., Hille B. (1972): The inner quaternary ammonium ion receptor in potassium channels of the node of Ranvier. J. Gen. Physiol. 59, 388-400
4. Bethge E. W., Bohuslavizki K. H., Hänsel W., Kneip A., Koppenhöfer E. (1991): Effects of some potassium channel blockers on the ionic currents in myelinated nerve. Gen. Physiol. Biophys. 10, 225-244
5. Bielik N., Farkas S., Kocsis P. (1997): Studies on the mechanism of action of RGH-5002, on centrally acting muscle relaxant, using whole cell patch champ technique. Neurobiol. (Budapest) 5, 43-45
6. Bohuslavizki K. H., Hänsel W., Kneip A., Koppenhöfer E., Reimers A. (1992): Potassium channel blockers from Ruta - a new approach for the treatment of multiple sclerosis. Gen. Physiol. Biophys. 11, 507-512
7. Bohuslavizki K. H., Hänsel W., Kneip A., Koppenhöfer E., Niemöller E. (1993a): Blocking of potassium channels in ranvier nodes by 1, 2, 3, 4, 10-substituted acridin -9-ons and its possible significance on demyelinating diseases. Gen. Physiol. Biophys. 12, 491-496
8. Bohuslavizki K. H., Hänsel W., Kneip A., Koppenhöfer E., Reimers A., Sanmann K. (1993b): Blocking of potassium channels in Ranvier nodes by 4, 5, 6, 7-substituted benzofurans and its significance on demyelinating diseases. Gen. Physiol. Biophys. 12, 293-301
9. Bohuslavizki K. H., Hinck-Kneip Ch., Kneip A., Koppenhöfer B., Reimers A. (1993c): Reduction of MS-related scotomata by a new class of potassium channel blockers from Ruta graveolens. Neuro-ophthalmol. 13, 191-198
10. Bohuslavizki K. H., Hänsel W., Kneip A., Koppenhöfer E., Niemöller E., Sanmann K. (1994a): Mode of action of psoralens, benzofurans, acridinons, and coumarins on the ionic currents in intact myelinated nerve fibres and its significance in demyelinating diseases. Gen. Physiol. Biophys. 13, 309-328
11. Bohuslavizki K. H., Kneip A., Koppenhöfer E. (1994b): State-of-the-art potential clamp device for myelinated nerve fibres using a new versatile input probe. Gen. Physiol. Biophys. 13, 357-376
12. Bokesch P. M., Post C., Strichartz G. (1986): Structure-activity relationship of lidocaine homologs producing tonic and frequency-dependent impulse blockade in nerve. J. Pharmacol. Exp. Ther. 237, 773-781
13. Brismar T. (1977): Slow mechanism for sodium permeability inactivation in myelinated nerve fibre of Xenopus laevis. J. Physiol. (London) 270, 283-297
14. Brismar T. (1983): IV. Nodal function of pathological nerve fibers. Experientia 39, 946-953
15. Brismar T., Schwarz J. R. (1985): Potassium permeability in rat myelinated nerve fibres. Acta physiol. scand. 124, 141-148
16. Courtney K. R. (1975): Mechanism of frequency-dependent inhibition of sodium currents in frog myelinated nerve by the lidocaine derivative GEA 968. J. Pharmacol. Exp. Ther. 195, 225-236
17. Dodge F. A., Frankenhaeuser B. (1958): Membrane currents in isolated frog nerve fibre under voltage clamp conditions. J. Physiol. (London) 143, 76-90
18. Dubois J. M. (1981): Evidence for the existence of three types of potassium channels in the frog Ranvier node membrane. J. Physiol. (London) 318, 297-316
19. + channels in the frog node of Ranvier. Brain Res. 245, 372-375
20. Düring T., Gerst F., Hänsel W., Wulff H., Koppenhöfer E. (2000): Effects of three alkoxypsoralens on voltage gated ion channels in Ranvier nodes. Gen. Physiol. Biophys. 19, 345-364
21. Farkas S., Kocsis P. L, Bielik N. (1997): Comparative characterisation of the centrally acting muscle relaxant RGH-5002 and tolperisone and of lidocaine based on their effects on rat spinal cord in vitro. Neurobiol. (Budapest) 5, 57-58
22. Frankenhaeuser B. (1957): A method for recording resting and action potentials in the isolated myelinated nerve fibre of the frog. J. Physiol. (London) 135, 550-559
23. Frankenhaeuser B. (1959): Steady state inactivation of sodium permeability in myelinated nerve fibres of Xenopus laevis. J. Physiol. (London) 148, 671-676
24. Frankenhaeuser B. (1963): A quantitative description of potassium currents in myelinated nerve fibres of Xenopus laevis. J. Physiol. (London) 169, 424-430
25. Franz D. N., Perry R. S. (1974): Mechanisms for differential block among single myelinated and non-myelinated axons by procaine. J. Physiol. (London) 236, 193-210
26. Hille B. (1977): Local anesthetics: hydrophylic and hydrophobic pathways for the drug-receptor reaction. J. Gen. Physiol. 69, 497-515
27. Hinck D., Wulff H., Koppenhöfer E. (2001): Gallamine triethiodide selectively blocks voltage-gated potassium channels in Ranvier nodes. Gen. Physiol. Biophys. 20, 83-95
28. Jedicke U., Haller R., Koppenhöfer E. (1988): Wirkung von Aminobenzoesäure-Derivaten auf die Ionenströme myelinisierter Nervenfasern. 1. Mitteilung: Dosis-Wirkungs-Beziehungen. Arzneim.-Forsch. 38 (I), 801-805 (in German)
29. Khodorov B., Sishkova L., Peganov E., Revenko S. (1976): Inhibition of sodium currents in frog Ranvier node treated with local anesthetics. Role of slow sodium inactivation. Biochim. Biophys. Acta 433, 409-435
30. Koh D. S., Jonas P., Bräu M. E., Vogel W. (1992): A TEA-if sensitive flickering potassium channel active around the resting potential in myelinated nerve. J. Membr. Biol. 130, 149-162
31. Koppenhöfer E., Sommer R.-G., Froese U. (1987): Effects of benzocaine and its isomers on sodium permeability and steady state sodium inactivation in the myelinated nerve, obtained by an improved dissection technique. Gen. Physiol. Biophys. 6, 209-222
32. Koppenhöfer E., Sommer R.-G. (1988): The effect of metacaine on the slow variation of peak sodium currents in potential clamped Ranvier nodes following changes in holding potential. Gen. Physiol. Biophys. 7, 225-234
33. Koppenhöfer E., Ditzen G., Gerst F., Reimers A. (1995): Kaliumkanalblocker in der Neurologie. 5-MOP zur Behandlung MS-bedingter Funktionsdefizite. TW Neurol. Psychiatrie 9, 585-591 (in German)
34. Pfaffendorf M. (1986a): Quantitative Untersuchungen zur Kopplung zwischen Rezeptor-Aktivierung und daraus resultierenden biologischen Effekten. Sci. Pharm. 54, 241 (in German)
35. Pfaffendorf M. (1986b): Observations on the coupling between receptor occupation and different consecutive effects. Naunyn-Schmiedeberg's Arch. Pharmacol. 332 (suppl.), R2
36. Reid G., Scholz A., Bostock H., Vogel W. (1999): Human axons contain at least five types of voltage-dependent potassium channel. J. Physiol. (London) 518, 681-696
37. Sachs L. (1984): Applied statistics. A handbook of techniques. Springer, New York.
38. Safronov B. V., Kampe K., Vogel W. (1993): Single voltage-dependent potassium channels in rat peripheral nerve membrane. J. Physiol. (London) 460, 675-691
39. Scholz A., Reid G., Vogel W., Bostock H. (1993): Ion channels in human axons. J. Neurophysiol. 70, 1274-1279
40. Schwarz J. R., Spielmann R. P. (1983): Flurazepam: effects on sodium and potassium currents in myelinated nerve fibres. Eur. J. Pharmacol. 90, 359-366
41. Schwarz J. R., Reid G., Bostock H. (1995): Action potentials and membrane currents in the human node of Ranvier. Pfluegers Arch. 430, 283-292
42. Shapiro B. I. (1977): Effects of strychnine on the potassium conductance of the frog node of Ranvier. J. Gen. Physiol. 69, 897-914
43. Stämpfli R., Hille B. (1976): Electrophysiology of the peripheral myelinated nerve. In: Frog Neurobiology (Eds. R. Llinas, W. Precht), pp. 3-32, Springer, Berlin
44. Strichartz G. R. (1973): The inhibition of sodium currents in myelinated nerve by quaternary derivatives of lidocaine. J. Gen. Physiol. 62, 37-57
45. Strichartz G. R. (1987): Local anesthetics. In: Handbook of experimental Pharmacology, (Eds. G. V. R. Born, A. R. Rensselaer, H. Herken, A. D. Welch), Vol. 81, Springer, Berlin
46. Zaciu C., Koppenhöfer E., Maskaliunas R. (1996): Reliability of ionic current measurements in Ranvier nodes. Gen. Physiol. Biophys. 15, 89-107